Carcinogenesis Advance Access originally published online on January 21, 2008
Carcinogenesis 2008 29(5):887-888; doi:10.1093/carcin/bgm272
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author 2007. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
Dr Jagadeesan Nair, Senior Scientist at the German Cancer Research Center (DKFZ) 1953–2007
Division of Toxicology and Cancer Risk Factors, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 290, Heidelberg, Germany
To whom correspondence should be addressed. Email: h.bartsch@dkfz.de
| The first 10% of the full text of this article appears below. |
Jagadeesan Nair died unexpectedly and prematurely on 28 August 2007 in Mumbai, India, as the consequence of a heart attack while returning from home leave to his research institute in Heidelberg, Germany. He was an internationally recognized pioneer in the field of cancer biomarkers and tobacco carcinogenesis. As he had always wondered why progress toward a cure of cancer had been slow, despite impressive international efforts, he set his hope on preventive measures, the efficacy of which could be assessed at an early stage by the application of the ultrasensitive, specific biomarkers that he had developed. We will miss him as a person of great kindness, modesty and integrity.
Jagadeesan Nair, born in 1953 in Pallipuram (Kerala), India, received his MSc (gold medalist) in 1975 and his PhD degree in chemistry in 1981 at Ravishankar University, Raipur, India. He started his research and professional experience in 1980 as